Skip to main content
logo
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.310
-0.060 (-1.78%)
Mar 20, 2026, 9:36 AM EDT - Market open

Recursion Pharmaceuticals Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Operating
74.26M43.42M64.51M59.82M58.49M64.60M48.62M45.23M
Operating Growth
26.96%-32.80%32.69%32.24%33.30%37.66%-2.52%-2.76%
Grant
425.00K274.00K82.00K-25.00K351.00K-1.01M1.00M
Grant Growth
21.08%--91.91%--49.79%-91,498.92%-
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.